Serum levels of iCAF-derived osteoglycin predict favorable outcome in pancreatic cancer

MLA

Mark P. G. Dings, et al. Serum Levels of ICAF-Derived Osteoglycin Predict Favorable Outcome in Pancreatic Cancer. Feb. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....fc3cf7b99880ba5044d3e85803aa329b&authtype=sso&custid=ns315887.

APA

Mark P. G. Dings, Paul Manoukian, Cynthia Waasdorp, Judith S. E. Quik, Marin Strijker, Sophie C. Lodestijn, Sanne M. van Neerven, Leandro F. Moreno, Rodrigo Leite de Oliveira, Bert A. Bonsing, Marco J. Bruno, Olivier R. Busch, Michael Doukas, Casper H. van Eijck, Nadia Haj Mohammad, Ignace H. de Hingh, Quintus I. Molenaar, Marc G. Besselink, Louis Vermeulen, … Maarten F. Bijlsma. (2023). Serum levels of iCAF-derived osteoglycin predict favorable outcome in pancreatic cancer.

Chicago

Mark P. G. Dings, Paul Manoukian, Cynthia Waasdorp, Judith S. E. Quik, Marin Strijker, Sophie C. Lodestijn, Sanne M. van Neerven, et al. 2023. “Serum Levels of ICAF-Derived Osteoglycin Predict Favorable Outcome in Pancreatic Cancer,” February. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....fc3cf7b99880ba5044d3e85803aa329b&authtype=sso&custid=ns315887.